Transcode Therapeutics Inc (RNAZ) — Net Asset Momentum
Transcode Therapeutics Inc (RNAZ) recorded a net asset momentum of 612.0% as of December 2025, with net assets of $10.34 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can Transcode Therapeutics Inc fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Transcode Therapeutics Inc Net Asset Momentum (2018–2025)
This chart tracks Transcode Therapeutics Inc's year-over-year net asset growth across 8 annual reporting periods from 2018 to 2025. The most recent momentum reading is +612.0%, with net assets of $10.34 Million USD as of December 2025. Read Transcode Therapeutics Inc balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Transcode Therapeutics Inc (2018–2025)
The table below shows the complete annual net asset history for Transcode Therapeutics Inc from 2018 to 2025, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of Transcode Therapeutics Inc.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $10.34 Million | $162.40 Million | $152.06 Million | ▲ +612.0% |
| 2024 | $-2.02 Million | $7.29 Million | $9.31 Million | ▼ -223.0% |
| 2023 | $1.64 Million | $5.17 Million | $3.53 Million | ▼ -49.4% |
| 2022 | $3.24 Million | $7.59 Million | $4.35 Million | ▼ -84.1% |
| 2021 | $20.40 Million | $22.94 Million | $2.53 Million | ▲ +698.7% |
| 2020 | $-3.41 Million | $1.06 Million | $4.46 Million | ▼ -210.5% |
| 2019 | $-1.10 Million | $216.74K | $1.31 Million | ▼ -117.8% |
| 2018 | $-503.97K | $214.65K | $718.61K | — |